Fierce Biotech - FDA's gene editing guidance is 'par for the course' but still important, analysts say

March 16, 2022

Featuring comments from Geulah Livshits, PhD on the FDA's Gene Editing Guidance.

Thank You!

We've received your information, and we're processing your request.

Get In Touch.

One Pennsylvania Plaza
Suite 4800
New York, NY 10119

One East Putnam Ave, 4th Fl. Greenwich, CT 06830

+1 646-465-9000

All fields required
SUBMIT